Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

埃皮菲巴提德和7E3,但不是蒂罗菲班,抑制了平滑肌肉细胞与血栓胺和前血栓胺的alpha(v) beta3整合因子介导的结合.

Robert M Scarborough

    Circulation
    |February 13, 2002
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor.

    Bioorganic & medicinal chemistry letters·2009
    Same author

    Anthranilamide-based N,N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors: P4 SAR.

    Bioorganic & medicinal chemistry letters·2009
    Same author

    Inhibitory effect of carboxylic acid group on hERG binding.

    Bioorganic & medicinal chemistry letters·2006
    Same author

    Identification of 4-piperazin-1-yl-quinazoline template based aryl and benzyl thioureas as potent, selective, and orally bioavailable inhibitors of platelet-derived growth factor (PDGF) receptor.

    Bioorganic & medicinal chemistry letters·2004
    Same author

    Protease-activated receptor-2 antagonists and agonists.

    Current medicinal chemistry. Cardiovascular and hematological agents·2004
    Same author

    Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deterioration.

    The Journal of biological chemistry·2004